Please note: this newsletter contains 17 more interesting announcements, which you may read at:

MAPS News September 2008

Dear MAPS Members, Supporters, and Friends,

It has been a productive and fun month for MAPS staff and associates. MAPS President Rick Doblin ventured to Portugal to help a psychedelic emergency services outreach team at the Boom festival. While there he laid the foundation for starting an MDMA/PTSD pilot study in Portugal. MAPS researcher Michael Mithoefer had a paper accepted to the leading conference on PTSD. Our guest editor David Jay Brown finished the summer edition of the MAPS Bulletin in time for him to take his first trip to Burning Man, where he reported “profound experiences.” Director of Operations Valerie Mojeiko, a seasoned psychedelic emergency outreach coordinator, officially became a Black Rock City Ranger. The night the Man burnt, acting like a skilled lion tamer, Valerie prevented anxious burners from rushing prematurely into dangerous flames. Hundreds of desert goers attended the psychedelic lecture series that MAPS hosted. They heard talks by myself and notable figures and researchers active in the psychedelic renaissance. Details about all of these items are found below.

Things will get even busier as we transition into fall. Over the next several months we will be preparing a paper on the completion of our MDMA/PTSD pilot study for journal publication. We are expecting to have full approval and to commence our Canadian MDMA/PTSD study. The study we are coordinating in Israel will treat more patients. The MDMA/PTSD treatment manual we have been working on will be finalized. Approval is in sight for our ibogaine outcome study. These are just some of the many research projects that keep all of us at MAPS very busy.

We can’t do this work without you! As a nonprofit organization we rely on the goodwill of our members to keep our research and educational projects funded. Can you chip in and donate to us today?

We are hosting a soireé at a Victorian mansion in San Francisco on October 11th to encourage new membership and to spend some time with current members. Details about the event are included in this email. I hope that I get to meet you at the soirée.

MAPS Flagship MDMA/PTSD Research to be Presented at International Society for Traumatic Stress Studies Conference:

The International Society for Traumatic Stress Studies (ISTSS), the largest organization in the world for researchers and therapists working with PTSD patients, has accepted a paper by MAPS-sponsored researcher Michael Mithoefer MD about his pioneering study of MDMA-assisted psychotherapy in 21 subjects with treatment-resistant posttraumatic stress disorder (PTSD). The 24th annual conference will take place in Chicago from November 13th through 15th.

The opportunity to offer a seminar at the ISTSS annual conference is a great accomplishment for Michael and the entire MAPS community. Last year, an application from Michael to present a poster about our PTSD research was rejected. The acceptance of the paper this year, now that his study has generated a clear safety record and compelling evidence of efficacy, demonstrates that information about MDMA-assisted psychotherapy is of interest to the organized, international community of PTSD researchers

Mithoefer is very pleased that his paper has been accepted rather than just a poster. “It will not only be more satisfying, I think it suggests a greater degree of interest in what we’re doing,” he said.

* * * Dues-paying MAPS members are empowering staff, scientists, and volunteers to carry out pioneering research and educational projects. To donate, learn about the benefits of MAPS membership, or purchase books, clothes, art, and other merchandise, visit: * * *

Not a member? You can read our bulletin online, but I bet you’d rather have a hard copy. Please become a member and support our burgeoning research and educational projects. We have membership categories for all income levels, basic memberships start at just $35! But if you can afford to donate more, we encourage you to do so.

In closing,

You can understand just how busy we are now that you have read though all of the various items. Please make a generous contribution today! We need to be funded in order for us to continue to get psychedelic therapy results noticed by mainstream professionals like the International Society for Traumatic Stress Studies and the mainstream press. The more ground we cover, the more the mainstream accepts us, the sooner we will pass through the regulatory hurdles for turning psychedelics into prescription medicines.

I look forward to sharing with you our progress and plans in next month’s email update.

Enthusiastically yours,

Randolph Hencken, MA BS
MAPS Communications and Marketing Director